作者
Marina Vignolo,L. Taddei,Pierluigi Garzia,Aldo Naselli,Edvige Veneselli,Giorgio Aicardi
摘要
By now, the association between cerebral calcification and epilepsy has been well established in patients diagnosed with celiac disease, often accompanied by folic acid deficiency (1-7). We report a patient with late-diagnosed celiac disease (CD) who developed epilepsy after 1 year on a gluten-free diet. CASE HISTORY In February 1990, a girl aged 10 years, 3 months was admitted for investigation of short stature. Her clinical history included neither neonatal distress nor seizures, but she suffered from recurrent episodes of vomiting and diarrhea, as well as poor growth and weight gain. On admission, physical examination revealed poor nutritional status, mild anemia, and abdominal distension. The results of laboratory analysis suggested CD (Table 1). This diagnosis was confirmed by peroral jejunal biopsy, which showed subtotal villous atrophy (third degree). A skull radiograph showed no cerebral calcifications. One year after starting a gluten-free diet, there was improvement in clinical, auxological, and laboratory parameters (Tables 1 and 2); but in February 1991 she had a first, partial seizure with secondary generalization. She relapsed monthly until she came under control in September 1991. During these 7 months, the patient's school performance deteriorated. A CT scan revealed bilateral parieto-occipital calcifications (Fig. 1). An EEG showed normal background activity but bilateral slow-spike and slow-wave complexes in the parieto-occipital regions that were more evident on the right side. These abnormalities were activated by sleep, mainly during the first and second stages. A psychometric test revealed an IQ of 73 (WISC R scale). Folate deficiency was identified (3.3 ng/ml; normal range, 3-17). Therapy with carbamazepine at a dosage of 20 mg/kg/day was started with transient satisfactory clinical response. Oral supplementation of folic acid was also started. Thereafter, she had atypical absences and an episode of amaurosis, followed by a generalized seizure. At 12 years (December 1991), a tonic clonic generalized seizure recurred, and therapy with sodium valproate (≈30 mg/kg/day) was started. No more generalized seizures occurred, although occasional atypical absences and short episodes of amaurosis still occur, mainly during the premenstrual period. At last EEG control, in September 1992, background activity showed a moderate degree of posterior slow rhythms and diffuse irregular slow-wave discharges, enhanced by eye closure. DISCUSSION Despite earlier reports that epilepsy, cerebral calcifications, and folic acid deficiency are associated with untreated celiac disease (6,8), in this case the onset of epilepsy occurred in a CD patient after 1 year of gluten-free diet. Cerebral occipital calcifications were revealed by CT scan at this time. There is no evidence that the occipital calcifications were already present on admission or that they developed during the 1st year of the diet, since before being placed on the diet the patient did not undergo CT scan. Normal skull radiograph is not sufficient to exclude the presence of endocranial calcifications (9). In any case, it is interesting to note that our patient, who was diagnosed with CD at the age of 10 years, developed epilepsy during the 1st year of a gluten-free diet, coincidental with a dramatic increase in height due to the catch-up growth associated with the initial adolescent pubertal spurt (Fig. 2). It is possible that this rapid growth phase increases the need for folic acid. Folic acid deficiency may play a role in the development of cerebral calcifications (3-8), but this hypothesis has not been proven. It is worth noting that our patient has not received any dietary folic acid supplementation and that her folic acid levels, as determined 1 year after beginning the diet, were at the lower limits of the normal range.FIG. 1.: Cerebral CT scan showing widespread calcifications in the cortical parieto-occipital region on both sides of the brain.FIG. 2.: Height and growth rate of the patient, as plotted on the Tanner et al. growth velocity chart.